PTAB challenges

The USPTO Open Data Portal (ODP) and my initial search instructions confirmed no AIA trial proceedings for US12502357 in the ODP API. My subsequent web search using terms like "US12502357 PTAB proceedings," "PTAB IPR US12502357," etc., did not yield any specific PTAB case numbers or decisions related to this patent. The search results primarily provided general information about the PTAB, how to search for decisions, and recent CAFC decisions on PTAB procedures, but nothing specific to US12502357.

This lack of specific results for a patent issued on December 23, 2025, is expected. The window for filing IPRs and PGRs is 9 months from the issue date, which is September 23, 2026. Given that the current date is May 30, 2026, there is still time for petitions to be filed. Even if a petition were filed very recently, an institution decision typically takes about 6 months, and a final written decision takes a year from institution. Thus, no final decisions would be available yet.

Therefore, I can confidently state that there are no PTAB proceedings on file for US12502357 based on the available information.## Proceedings Overview

As of today, May 30, 2026, there are no AIA trial proceedings on file for US Patent 12502357. This means the patent has not been challenged through Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) review at the Patent Trial and Appeal Board (PTAB). For a defendant, this indicates that all claims of the patent are currently unchallenged at the PTAB, and the patent's validity has not been tested in this forum.

No PTAB Activity on File

• Type: N/A
• Filed: N/A
• Status: No AIA trial proceedings have been filed for US Patent 12502357. This information is based on the USPTO Open Data Portal API and confirmed by web searches for PTAB proceedings.
• Judge panel: N/A
• Petition grounds: N/A
• Institution decision: N/A
• Final Written Decision: N/A
• Settlement / termination: N/A
• Appeal: N/A
• Defensive value: The absence of PTAB proceedings means that, as of today, no claims of US Patent 12502357 have been challenged or invalidated by the PTAB. Any assertion of this patent currently relies on claims that have not undergone AIA trial scrutiny.

Strategic Summary

All claims of US Patent 12502357 are currently UNTESTED at the PTAB. Since the patent was issued on December 23, 2025, the 9-month window for filing IPR or PGR petitions is still open (expiring around September 23, 2026). Consequently, there are no canceled or sustained claims from PTAB proceedings.

The estoppel landscape is entirely open. Since no PTAB trial has been instituted, there are no estoppel effects under 35 U.S.C. § 315(e)(2) for any potential petitioner or their privies. All prior-art grounds, including those discussed in the "Obviousness" section (e.g., combining US 7,709,517 with general knowledge of amorphous solid dispersions), remain available for a future challenge.

There are no discernible pattern signals regarding petitioner behavior or patent owner's PTAB defense strategy, as no proceedings exist for this specific patent.

Recommended Next Steps

If you are a defendant facing potential assertion of US Patent 12502357, the primary recommendation is to:

1. Evaluate for PTAB Challenge: Given the patent's recent issuance and the identified "strong prima facie case for the obviousness of the core claims" (as stated in the "Obviousness" section of this analysis), consider filing an Inter Partes Review (IPR) petition. The deadline for filing an IPR or Post-Grant Review (PGR) petition is 9 months from the patent's issue date of December 23, 2025, which falls around September 23, 2026. This period is critical for assessing the patent's vulnerability to PTAB challenges.
2. Monitor Filings: Continuously monitor the USPTO's Patent Trial and Appeal Case Tracking System (P-TACTS) for any IPR, PGR, or CBM petitions filed against US Patent 12502357 by other parties. The absence of current PTAB activity suggests that the patent's validity has not been tested, but this situation could change quickly as the 9-month window for filing IPRs/PGRs is still active.
3. Conduct Internal Review: Perform a detailed internal prior art search and obviousness analysis against the specific claims of US Patent 12502357, if available, to identify the strongest possible grounds for invalidity, in preparation for a potential PTAB challenge or district court defense.